124 related articles for article (PubMed ID: 4246488)
21. [Biomedical study of Down's syndrome].
Nakamura T
Nihon Shonika Gakkai Zasshi; 1970 Mar; 74(3):400-11. PubMed ID: 4192691
[No Abstract] [Full Text] [Related]
22. Solubility behaviour of phosphofructokinase from haemolysate of erythrocytes, reticulocytes and bone marrow cells in poly (ethylene glycol) solutions.
Tejedor MC; Delgado C; Luque J
Biochem Int; 1991 Jan; 23(1):59-67. PubMed ID: 1830739
[TBL] [Abstract][Full Text] [Related]
23. [Quantitative enzymic determination of galactokinase activity in the erythrocyte haemolysate of patients with Down's syndrome (author's transl)].
Lippross S; Menne F
Z Klin Chem Klin Biochem; 1974 Oct; 12(10):449-52. PubMed ID: 4279510
[No Abstract] [Full Text] [Related]
24. Platelet monoamine oxidase activity in Down's syndrome.
Fowler CJ; Wiberg A; Gustavson KH; Winblad B
Clin Genet; 1981 May; 19(5):307-11. PubMed ID: 6457707
[TBL] [Abstract][Full Text] [Related]
25. [Trisomy-21 with deficiency of erythrocyte-phosphofructokinase].
Schwarzmeier J; Moser K; Zimprich H; Weiss I
Z Kinderheilkd; 1970; 108(4):325-30. PubMed ID: 4252955
[No Abstract] [Full Text] [Related]
26. Leucocyte alkaline phosphatase and erythrocyte glucose-6-phosphate dehydrogenase in Down's Syndrome.
Phillips J; Herring RM; Goodman HO; King JS
J Med Genet; 1967 Dec; 4(4):268-73. PubMed ID: 4230173
[No Abstract] [Full Text] [Related]
27. [Significance of the type of chromosome aberrations and biochemical disorders for diagnosis of Down's syndrome and the phenotype of partial trisomy 21].
Mikiel-Kostyra K; Czerski P; Bartosz G; Sito A; Leyka W
Pediatr Pol; 1980 Jan; 55(1):23-32. PubMed ID: 6445053
[No Abstract] [Full Text] [Related]
28. Moderate Down's syndrome in three siblings having partial trisomy 21q22.2 to qter and therefore no SOD-1 excess.
Habedank M; Rodewald A
Hum Genet; 1982; 60(1):74-7. PubMed ID: 6210617
[No Abstract] [Full Text] [Related]
29. Diminished activity of platelet monoamine oxidase in Down's syndrome.
Benson PF; Southgate J
Arch Dis Child; 1970 Oct; 45(243):714. PubMed ID: 4249052
[No Abstract] [Full Text] [Related]
30. Lipid peroxides in blood plasma and enzymatic antioxidative defence of erythrocytes in Down's syndrome.
Kedziora J; Bartosz G; Gromadzińska J; Skłodowska M; Wesowicz W; Scianowski J
Clin Chim Acta; 1986 Feb; 154(3):191-4. PubMed ID: 2937579
[TBL] [Abstract][Full Text] [Related]
31. Blood cell pyruvate kinase activity in translocation Down's syndrome.
Sparkes RS; Baughan MA
Humangenetik; 1969; 7(3):253-4. PubMed ID: 4241255
[No Abstract] [Full Text] [Related]
32. [Mosaic Down's syndrome].
Grosse KP; Grosse G; Schwanitz G; Rott HD
Z Kinderheilkd; 1971; 110(4):332-46. PubMed ID: 4254864
[No Abstract] [Full Text] [Related]
33. [Familial pericentric inversion of y chromosome and Down's syndrome].
García Sagredo JM; Morán Cabré A; San Román Cos-Gayón C
An Esp Pediatr; 1975; 8(1):68-71. PubMed ID: 123717
[TBL] [Abstract][Full Text] [Related]
34. De novo translocation Down's syndrome: risk of recurrence of Down's syndrome.
Gardner RJ; Veale AM
Clin Genet; 1974; 6(3):160-4. PubMed ID: 4279152
[No Abstract] [Full Text] [Related]
35. A case of 47,XX,(21q-)+ with some stigmata of Down's syndrome and an IQ of 77.
Neu RL; Voorhess ML; Gardner LI
J Med Genet; 1971 Dec; 8(4):528-9. PubMed ID: 4261059
[No Abstract] [Full Text] [Related]
36. [Significance of chromosome translocations from the G-D group in the karyotype of the mother of 2 children with Down's syndrome].
Dobrzańska A; Kostrzewski J
Pediatr Pol; 1970 Feb; 45(2):211-5. PubMed ID: 4245096
[No Abstract] [Full Text] [Related]
37. A Gq deletion in a girl with Down's syndrome.
Hongell K; Airaksinen E
Hum Hered; 1972; 22(1):80-5. PubMed ID: 4260912
[No Abstract] [Full Text] [Related]
38. Erythrocyte enzymes in Down's syndrome.
Rosner F
Lancet; 1970 May; 1(7653):951. PubMed ID: 4191575
[No Abstract] [Full Text] [Related]
39. Distinguishing between the chromosomes involved in Down's syndrome (trisomy 21) and cronic myeloid leukaemia (Ph1) by fluorescence.
O'Riordan ML; Robinson JA; Buckton KE; Evans HJ
Nature; 1971 Mar; 230(5290):167-8. PubMed ID: 4100531
[No Abstract] [Full Text] [Related]
40. Elevated erythrocyte adenosine deaminase activity in Down's syndrome.
Puukka R; Puukka M; Linna SL; Joensuu T; Kouvalainen K
Acta Paediatr Scand; 1981 Sep; 70(5):739-41. PubMed ID: 6459708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
